Spero Therapeutics, Inc. (SPRO) Earnings Dates & History
NASDAQ·Healthcare·Biotechnology
$2.83
+4.63%
Mkt Cap $130.71M
EPS — Estimate vs Actual
Quarterly History
| Q1 2026 May 13, 2026 | $43.34M | $258.00K | -99.40% | -$0.18 | -$0.13 | +27.78% |
| Q1 2026 Mar 26, 2026 | $26.00M | $41.30M | +58.83% | -$0.20 | $0.53 | +365.00% |
| Q4 2025 Nov 13, 2025 | $12.00M | $3.05M | -74.60% | -$0.25 | -$0.13 | +48.00% |
| Q3 2025 Aug 12, 2025 | $11.00M | $11.80M | +7.29% | -$0.38 | -$0.03 | +92.11% |
| Q2 2025 May 13, 2025 | $11.00M | $5.87M | -46.60% | -$0.55 | -$0.25 | +54.55% |
| Q1 2025 Mar 27, 2025 | $6.20M | $9.36M | +50.90% | -$0.35 | -$0.38 | -8.57% |
| Q4 2024 Nov 14, 2024 | $4.13M | $13.47M | +225.86% | -$0.27 | -$0.32 | -18.52% |
| Q3 2024 Aug 5, 2024 | $4.90M | $6.02M | +22.80% | -$0.35 | -$0.33 | +5.71% |
| Q2 2024 May 15, 2024 | $21.53M | $4.20M | -80.47% | -$0.07 | -$0.24 | -242.86% |
| Q1 2024 Mar 13, 2024 | $18.63M | $71.83M | +285.54% | -$0.10 | $0.96 | +1060.00% |
| Q4 2023 Nov 13, 2023 | $26.63M | $25.47M | -4.34% | -$0.15 | $0.02 | +113.33% |
| Q3 2023 Aug 10, 2023 | $11.03M | $788.00K | -92.86% | -$0.29 | -$0.23 | +20.69% |
| Q2 2023 May 11, 2023 | $1.00M | $740.00K | -26.00% | -$0.35 | -$0.25 | +28.57% |
| Q1 2023 Mar 30, 2023 | $22.87M | $46.30M | +102.46% | $0.04 | $0.55 | +1169.33% |
| Q4 2022 Nov 14, 2022 | $5.42M | $1.08M | -80.02% | -$0.34 | -$0.33 | +2.94% |
| Q3 2022 Aug 10, 2022 | $1.43M | $896.00K | -37.49% | -$0.88 | -$0.87 | +1.14% |
| Q2 2022 May 16, 2022 | $1.93M | $247.00K | -87.17% | -$0.87 | -$1.01 | -16.09% |
| Q1 2022 Mar 31, 2022 | $4.95M | $2.74M | -44.57% | -$0.80 | -$0.90 | -12.50% |
| Q4 2021 Nov 10, 2021 | $3.06M | $3.06M | +0.00% | -$0.70 | -$0.70 | +0.00% |
| Q3 2021 Aug 5, 2021 | $5.15M | $5.15M | +0.00% | -$0.77 | -$0.63 | +18.18% |
| Q2 2021 May 6, 2021 | $3.67M | $7.30M | +98.91% | -$0.61 | -$0.66 | -8.20% |
| Q1 2021 Mar 11, 2021 | — | $1.91M | — | -$0.77 | -$0.68 | +11.69% |
| Q4 2020 Nov 5, 2020 | $573.59K | $4.00M | +596.49% | -$0.91 | -$0.86 | +5.49% |
| Q3 2020 Aug 6, 2020 | $2.28M | $1.73M | -24.11% | -$1.17 | -$0.85 | +27.35% |
| Q2 2020 May 8, 2020 | $1.74M | $169.00K | -90.30% | -$1.35 | -$1.22 | +9.63% |
| Q1 2020 Mar 16, 2020 | $2.97M | $696.00K | -76.57% | -$1.09 | -$1.32 | -21.10% |
| Q4 2019 Nov 4, 2019 | $4.15M | $172.00K | -95.86% | -$0.80 | -$0.95 | -18.75% |
| Q3 2019 Aug 8, 2019 | $1.89M | $2.16M | +13.85% | -$0.57 | -$0.74 | -29.82% |
| Q2 2019 May 9, 2019 | $20.76M | $3.81M | -81.66% | -$0.77 | -$0.29 | +62.34% |
| Q1 2019 Mar 14, 2019 | $2.12M | $1.69M | -20.00% | -$0.76 | -$0.60 | +21.05% |
| Q4 2018 Nov 8, 2018 | $690.90K | $658.00K | -4.76% | -$0.64 | -$0.60 | +6.25% |
| Q3 2018 Aug 9, 2018 | $516.68K | $463.00K | -10.39% | -$0.88 | -$0.69 | +21.59% |
| Q2 2018 May 10, 2018 | $1.87M | $1.15M | -38.33% | -$1.31 | -$0.74 | +43.51% |
| Q2 2018 Apr 2, 2018 | $978.96K | $993.00K | +1.43% | -$1.56 | -$1.59 | -1.92% |
| Q4 2017 Dec 14, 2017 | — | $597.00K | — | -$2.43 | -$36.02 | -1382.30% |
| Q2 2017 Jun 30, 2017 | — | $249.00K | — | — | -$1.39 | — |
| Q1 2017 Mar 31, 2017 | — | $140.00K | — | — | -$0.89 | — |
| Q4 2016 Dec 31, 2016 | — | $335.00K | — | — | -$1.09 | — |
| Q3 2016 Sep 30, 2016 | — | — | — | — | -$0.96 | — |